{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:40:53Z","timestamp":1779331253110,"version":"3.51.4"},"reference-count":15,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2021,9,30]]},"DOI":"10.7883\/yoken.jjid.2020.827","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T22:09:40Z","timestamp":1611871780000},"page":"416-420","source":"Crossref","is-referenced-by-count":3,"title":["Nasopharyngeal SARS-CoV-2 Viral Load Response among COVID-19 Patients Receiving Favipiravir"],"prefix":"10.7883","volume":"74","author":[{"given":"Weerawat","family":"Manosuthi","sequence":"first","affiliation":[{"name":"Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somlerk","family":"Jeungsmarn","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilailuk","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawita","family":"Suwanvattana","sequence":"additional","affiliation":[{"name":"Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warawan","family":"Wongboot","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unchana","family":"Thawornwan","sequence":"additional","affiliation":[{"name":"Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lantharita","family":"Charoenpong","sequence":"additional","affiliation":[{"name":"Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasak","family":"Wiboonchutikul","sequence":"additional","affiliation":[{"name":"Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumonmal","family":"Uttayamakul","sequence":"additional","affiliation":[{"name":"Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wannarat A.","family":"Pongpirul","sequence":"additional","affiliation":[{"name":"Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichat","family":"Wachirapan","sequence":"additional","affiliation":[{"name":"Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paijit","family":"Warachit","sequence":"additional","affiliation":[{"name":"Office of the Permanent Secretary, Ministry of Public Health, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pongpirul WA, Pongpirul K, Ratnarathon AC, et al. Journey of a Thai taxi driver and novel coronavirus. N Engl J Med. 2020;382:1067-8.","DOI":"10.1056\/NEJMc2001621"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92:401-2.","DOI":"10.1002\/jmv.25678"},{"key":"3","unstructured":"3. World Health Organization (WHO). Clinical Management of COVID-19:Interim Guidance. Geneva:WHO;2020. Available at <https:\/\/www.who.int\/publications\/i\/item\/clinical-management-of-covid-19\/>. Accessed September 10, 2020."},{"key":"4","unstructured":"4. Infectious Diseases Society of America (IDSA). IDSA guidelines on the treatment and management of patients with COVID-19. Available at <https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/>. Accessed September 10, 2020."},{"key":"5","unstructured":"5. Ministry of Public Health, Thailand. Guidelines for clinical practice, diagnosis, treatment and prevention of healthcare-associated infection in response to patients with COVID-19 infection (April 8, 2020). Available at <https:\/\/ddc.moph.go.th\/viralpneumonia\/eng\/file\/guidelines\/g_CPG.pdf>. Accessed September 10, 2020."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39:405-7.","DOI":"10.1016\/j.healun.2020.03.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chen J, Qi T, Liu L, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80:e1-e6.","DOI":"10.1016\/j.jinf.2020.03.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Agrawal U, Raju R, Udwadia ZF. Favipiravir: a new and emerging antiviral option in COVID-19. Med J Armed Forces India. 2020;76:370-6.","DOI":"10.1016\/j.mjafi.2020.08.004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016;13:e1001967.","DOI":"10.1371\/journal.pmed.1002066"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bai CQ, Mu JS, Kargbo D, et al. Clinical and virological characteristics of ebola virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014. Clin Infect Dis. 2016;63:1288-94.","DOI":"10.1093\/cid\/ciw571"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cai Q, Yang M, Liu D, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering. 2020;6:1192-8.","DOI":"10.1016\/j.eng.2020.03.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Doi Y, Hibino M, Hase R, et al. A prospective, randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19. Antimicrob Agents Chemother. 2020;64:e01897-20.","DOI":"10.1128\/AAC.01897-20"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Choy KT, Wong AY, Kaewpreedee P, et al. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res. 2020;178:104786.","DOI":"10.1016\/j.antiviral.2020.104786"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the reentry emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269-71.","DOI":"10.1038\/s41422-020-0282-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bwire GM, Majigo MV, Njiro BJ, et al. Detection profile of SARS\u2010CoV\u20102 using RT\u2010PCR in different types of clinical specimens: a systematic review and meta\u2010analysis. J Med Virol. 2021;93:719-25.","DOI":"10.1002\/jmv.26349"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/5\/74_JJID.2020.827\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T03:47:39Z","timestamp":1632541659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/5\/74_JJID.2020.827\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2020.827","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"article-number":"JJID.2020.827"}}